New Drug Targets Lymphoma, Cuts Side Effects

by: mdanderson
February 27, 2012
DOI: 10.4016/39488.01
112 views
URL
Embed
Share

Please describe the reason for abuse:



Description:
MD Anderson's Dr. Michael Rytting and ALCL survivor Logan Emmons discuss impact of brentuximab vedotin.

Belongs to: